Zobrazeno 1 - 10
of 20
pro vyhledávání: '"John DesJardins"'
Publikováno v:
2018 ASEE Annual Conference & Exposition Proceedings.
Publikováno v:
Scopus-Elsevier
Publikováno v:
Scopus-Elsevier
Autor:
Randolph Hutchison, Jessica Myers, Nicholas Hayden, Lee Shearer, Kaitlin Bruneau, John DesJardins
Publikováno v:
Journal of Functional Morphology and Kinesiology; Volume 2; Issue 3; Pages: 32
Journal of Functional Morphology and Kinesiology, Vol 2, Iss 3, p 32 (2017)
Journal of Functional Morphology and Kinesiology, Vol 2, Iss 3, p 32 (2017)
The anterior cruciate ligament (ACL) is one of the most commonly injured ligaments, with over 250,000 injuries per year in the United States. Previous studies have found that ACL-deficient individuals avoid use of the quadriceps in the injured limb a
Publikováno v:
Journal of surgical orthopaedic advances. 26(1)
Cannulated screws are widely used for the treatment of slipped capital femoral epiphysis; however, the optimal choice and number of implants have not been clearly defined. Studies have shown that two screws are biomechanically superior to a single sc
Publikováno v:
2016 ASEE Annual Conference & Exposition Proceedings.
Autor:
Daniel W. Drolet, Eric N. Brown, John Desjardins, Dorothy B. Colagiovanni, Elizabeth Abbott, David L. Emerson
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 309:894-902
OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] is a liposomal formulation of the highly specific, noncompetitive, thymidylate synthase inhibitor OSI-7904 (also known as GW1843,
Autor:
Ray Bendele, John Desjardins, Susan Karimi, Beth Abbott, Frank C. Richardson, Dennis J. Meyer, Greg Biesecker
Publikováno v:
Antiviral Research. 58:217-225
The antiviral compound tenofovir DF (Gilead Sciences) was evaluated for possible mitochondrial toxicity in rats, rhesus monkeys and woodchucks. Animals were treated by oral gavage with tenofovir DF, and the levels of mitochondrial enzymes cytochrome
Autor:
Mieke Ptaszynski, Elizabeth Abbott, Frank C. Richardson, Larry Dihel, Eric N. Brown, Jeremy D. Leray, John Desjardins, David L. Emerson, Raymond A. Bendele, Marta Hamilton, Blake Tomkinson
Publikováno v:
Anti-Cancer Drugs. 12:235-245
Prolonging tumor exposure to topoisomerase I inhibitors has been correlated to enhance the efficacy of those agents. Lurtotecan, a water-soluble camptothecin analog, was formulated as a liposomal drug, NX211, to enhance the delivery of drug to tumors
Autor:
John Desjardins, Vikram Arora, Rajashree Joshi, Kenneth J. Himmelstein, Patrick L. Iversen, Dennis H. Robinson
Publikováno v:
Pharmaceutical Research. 15:1189-1195
Purpose. This study characterizes the in vivoproperties of an in situforming gel, comprising an IPC of water-soluble polymers, PMA and PEG, for sustained release of macromolecular drugs. Methods. 40, 50 or 60% w/v formulations were injected subcutane